Clinical Operations Associate Director (Biotechnology / Oncology)
Exelixis
About this role
The Clinical Operations Associate Director leads the design, execution, and reporting of oncology clinical trials, managing study delivery from early to late phase using various delivery models. The role involves strategic planning, vendor management, compliance oversight, and team leadership to ensure successful clinical trial outcomes.
Skills
About Exelixis
exelixis.comExelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
Recent company news
BitgetExelixis (EXEL) Has Fallen 2.8% Since Its Previous Earnings Report: Is a Recovery Possible?
4 hours ago
Fierce PharmaExelixis aims to be a top-5 solid tumor drugmaker in the US: CEO
1 month ago
MarketBeatWhat is Zacks Research's Estimate for Exelixis Q3 Earnings?
3 days ago
Investing.com NigeriaExelixis Q4 2025 slides: Strong earnings growth amid oncology franchise expansion
2 days ago
Business WireExelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March
2 weeks ago
About Exelixis
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Exelixis.
Salary
$195k – $278k
per year
More jobs at Exelixis
Similar Jobs
Senior Clinical Trial Manager, Clinical Operations (EU)
Iambic Therapeutics
Associate Director, Clinical Operations (Late-Phase)
Latigobio
Senior Director, Oncology Clinical Trial Operations
Natera
Late Stage Oncology Clinical Scientist (Director, Non MD) Multiple Positions
Pfizer
Clinical Scientist Director, Late Development GU Oncology
Amgen
Clinical Imaging Scientific Director (Oncology)
Regeneron Pharmaceuticals